Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia

Internal Medicine Journal

Volumn 35, Issue 9, 2005, Pages 518-525

  Kovoor, Pramish ^a   Love, A ^b   Hall, J ^b   Kruit, R ^b   Sadick, N ^a   Ho, D ^a   Adelstein, B A ^b   Ross, D L ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b Greater Sydney Area Helicopter Emergency Medical Service Ambulance Service New South Wales Rescue Helicopter Base Bankstown Airport   (Australia)

Author keywords

Lignocaine; Out of hospital cardiac arrest; Randomized; Sotalol; Ventricular fibrillation

Indexed keywords

ADRENALIN; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHLORIDE; DIGOXIN; DIURETIC AGENT; LIDOCAINE; PLACEBO; SOTALOL;

ADULT; AGED; ARTICLE; ASYSTOLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAMEDICAL PERSONNEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HUMANS; LIDOCAINE; MALE; OUTPATIENTS; RETROSPECTIVE STUDIES; SOTALOL; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 24744461858     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00896.x     Document Type: Article

References (44)

1. Gueugniaud PY, Mols P, Goldstein P, Pham E, Dubien PY, Deweerdt C et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. N Engl J Med 1998; 339: 1595-601.
2. Emergency Cardiac Care Committee and Subcommittees - American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care, I: adult advanced cardiac life support. JAMA 1992; 268: 2199-241.
3. Herlitz J, Ekstrom L, Wennerblom B, Axelsson A, Bang A, Lindkvist J et al. Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival? Resuscitation 1997; 33: 199-205.
4. Harrison EE. Lidocaine in prehospital countershock refractory ventricular fibrillation. Ann Emerg Med 1981; 10: 420-23.
5. Weaver WD, Fahrenbruch CE, Johnson DD, Hallstrom AP, Cobb LA, Copass MK. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation 1990; 82: 2027-34.
6. van Walraven C, Stiell IG, Wells GA, Hebert PC, Vandemheen K. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC Study Group. Ann Emerg Med 1998; 32: 544-53.
7. Jones DL, Klein GJ, Guiraudon GM, Yee R, Brown JE, Sharma AD. Effects of lidocaine and verapamil on defibrillation in humans. J Electrocardiol 1991; 24: 299-305.
8. Ware DL, Atkinson JB, Brooks MJ, Echt DS. Ventricular defibrillation in canines with chronic infarction, and effects of lidocaine and procainamide. Pacing Clin Electrophysiol 1993; 16: 337-46.
9. Topham SL, Cha YM, Peters BB, Chen PS. Effects of lidocaine on relation between defibrillation threshold and upper limit of vulnerability in open-chest dogs. Circulation 1992; 85: 1146-51.
10. Ujhelyi MR, Sims JJ, Miller AW. High-dose lidocaine does not affect defibrillation efficacy: implications for defibrillation mechanisms. Am J Physiol 1998; 274: H1113-20.
11. Guarnieri T, Levine JH, Veltri EP, Griffith LS, Watkins L, Juanteguy J et al. Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator. Am J Cardiol 1987; 60: 1061-4.
12. Jung W, Manz M, Pizzulli L, Pfeiffer D, Luderitz B. Effects of chronic amiodarone therapy on defibrillation threshold. Am J Cardiol 1992; 70: 1023-7.
13. Krafchek J, Lin H, Beckman KJ, Nielson AP, Magro SA, Hargis J et al. Cumulative effects of amiodarone on inducibility of ventricular tachycardia: implications for electrophysiol testing. Pacing Clin Electrophysiol 1988; 11: 434-44.
14. Greenspon AJ, Volosin KJ, Greenberg RM, Jefferies L, Rotmensch HH. Amiodarone therapy: role of early and late electrophysiologic studies. J Am Coll Cardiol 1988; 11: 117-23.
15. Rosenheck S, Sousa J, Calkins H, Schmaltz S, deBuitleir M, Kadish AH et al. Comparison of the results of electrophysiological testing after short-term and long-term treatment with amiodarone in patients with ventricular tachycardia. Am Heart J 1991; 121: 1693-8.
16. Frame LH. The effect of chronic oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs. Pacing Clin Electrophysiol 1989; 12: 339-46.
17. Spinelli W, Parsons RW, Colatsky TJ. Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol. J Cardiovasc Pharmacol 1992; 20: 913-22.
18. Wang M, Dorian P. DL and D sotalol decrease defibrillation energy requirements. Pacing Clin Electrophysiol 1989; 12: 1522-9.
19. Dorian P, Newman D, Sheahan R, Tang A, Green M, Mitchell J. d-Sotalol decreases defibrillation energy requirements in humans: a novel indication for drug therapy. J Cardiovasc Electrophysiol 1996; 7: 952-61.
20. Ditchey RV, Rubio-Perez A, Slinker BK. Beta-adrenergic blockade reduces myocardial injury during experimental cardiopulmonary resuscitation. J Am Coll Cardiol 1994; 24: 804-12.
21. Anderson JL, Rodier HE, Green LS. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol 1983; 51: 1196-202.
22. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999; 341: 871-8.
23. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with Lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002; 346: 884-90.
24. Ho DSW, Zecchin RP, Richards DAB, Uther JB, Ross DL. Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia. Lancet 1994, 344: 18-23.
25. Ho DS, Zecchin RP, Cooper MJ, Richards DA, Uther JB, Ross DL. Rapid intravenous infusion of d-1 sotalol: time to onset of effects on ventricular refractoriness, and safety. Eur Heart J 1995; 16: 81-6.
26. Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett PJ, Becker L et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation 1991; 84: 960-75.
27. Oakenfull E. Uniform random number generators and the spectral test. In: Neil DM, ed. Interactive Statistics. Amsterdam: North Holland; 1979; 61-8.
28. Kern KB, Hilwig RW, Berg RA, Rhee KH, Sanders AB, Otto CW et al. Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. Circulation 1997; 95: 2610-13.
29. Kovoor P, Eipper V, Byth K, Cooper MJ, Uther JB, Ross DL. Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease. Eur Heart J 1999; 20: 364-74.
30. Haynes RE, Chinn TL, Copass MK, Cobb LA. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. Am J Cardiol 1981; 48: 353-6.
31. Olson DW, Thompson BM, Darin JC, Milbrath MH. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med 1984; 13: 807-10.
32. Kuisma M, Maatta T. Out-of-hospital cardiac arrests in Helsinki: Utstein style reporting. Heart 1996; 76: 18-23.
33. Crone PD. Auckland Ambulance Service cardiac arrest data 1991-3. N Z Med J 1995; 108: 297-9.
34. Pearson S, Ardagh M, Stokes R. Survival from out of hospital cardiac arrest in Christchurch 1992-3. N Z Med J 1996; 109: 187-9.
35. Stiell IG, Wells GA, Field BJ, Spaite DW, De Maio VJ, Ward R et al. Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: OPALS study phase II. Ontario Prehospital Advanced Life Support. JAMA 1999; 281: 1175-81.
36. Lombardi G, Gallagher J, Gennis P. Outcome of out-of-hospital cardiac arrest in New York City. The Pre-Hospital Arrest Survival Evaluation (PHASE) Study. JAMA 1994; 271: 678-83.
37. Cobb LA, Fahrenbruch CE, Walsh TR, Copass MK, Olsufka M, Breskin M et al. Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation. JAMA 1999; 281: 1182-8.
38. White RD, Asplin BR, Bugliosi TF, Hankins DG. High discharge survival rate after out-of-hospital ventricular fibrillation with rapid defibrillation by police and paramedics. Ann Emerg Med 1996; 28: 480-85.
39. Herlitz J, Ekstrom L, Wennerblom B, Axelsson A, Bang A, Holmberg S. Effect of bystander initiated cardiopulmonary resuscitation on ventricular fibrillation and survival after witnessed cardiac arrest outside hospital. Br Heart J 1994; 72: 408-12.
40. Becker L, Eisenberg M, Fahrenbruch C, Cobb L. Public locations of cardiac arrest. Implications for public access defibrillation. Circulation 1998; 97: 2106-9.
41. Griffith MJ, Linker NJ, Garratt CJ, Ward DE, Camm AJ. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. Lancet 1990; 336: 670-73.
42. Waldo A, Camm A, deRuyter H, Friedman P, MacNeil D, Pauls J et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348: 7-12.
43. Nademanee K, Feld G, Hendrickson JA, Singh PN, Singh BN. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias. Circulation 1985; 72: 555-63.
44. Aupetit JF, Timour Q, Loufoua-Moundanga J, Barral-Cadiere L, Lopez M, Freysz M et al. Profibrillatory effects of lidocaine in the acutely ischemic porcine heart. J Cardiovasc Pharmacol 1995; 25: 810-16.